Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-23-013872

Chief Financial Officer sold 70,000 shares at $8.53 ($597,100)

  • Chief Financial Officer acquired 14,328 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PETERSON TYCHO Chief Financial Officer 2023-06-15 Sale 10b5-1 −55,672 $8.53 $474,882 399,219 D: show line 1 in the form
PETERSON TYCHO Chief Financial Officer 2023-06-15 Option exercise 10b5-1 +14,328 $7.30 $104,594 413,547 D: show line 2 in the form
PETERSON TYCHO Chief Financial Officer 2023-06-15 Sale 10b5-1 −14,328 $8.53 $122,218 399,219 D: show line 3 in the form
Open-market sales · 70,000 sh · avg $8.53 · $597,100

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
PETERSON TYCHO Chief Financial Officer 2023-06-15 Option exercise · Stock Option (right to buy) 10b5-1 −14,328 582,829 D: show line 4 in the form
Loading xslF345X04/form4.xml…